Meet the team

Meet the Healthcare Gateway Team


Susan Smith

Sue Smith profile

Lead Knowledge Exchange and Commercialisation Manager

Susan manages the Healthcare Gateway team and has responsibility for the development of varied projects emerging from cardiovascular research (pharmaceutical and device interventions as well as software simulation). She supports the development of significant translational funding bids, the protection & licensing of intellectual property as well as spin-out formation. Before taking up her position, Susan spent five years as a Research Translator in the Department of Biomedical Science, Sheffield, and has 7 years experience working in biotech firms in Germany and the US. Susan has a PhD from the European Molecular Biology Laboratory in Heidelberg and a BA (Hons) in Biochemistry from Oxford University.

Susan is responsible for the department of Infection, Immunity and Cardiovascular Disease


Thomas Bartlett

Thomas Bartlett profile

Knowledge Exchange and Commercialisation Manager

Tom has experience with spin-out company incorporation, the development of large translational funding bids, the protection & licensing of intellectual property and the negotiation of complex multi-party research agreements. Tom previously identified and evaluated new therapeutic approaches for the Centre for Drug Research and Development in Canada. Tom has a degree in Biochemistry and a PhD in Neuroscience from the University of Bristol. 

Tom currently works with researchers in the Department of Neuroscience


Nicola Galley 

Nicola Galley Profile - Healthcare Gateway Team

Knowledge Exchange and Commercialisation Manager

Nicola completed her PhD in Life Sciences at the University of Warwick. Following this she moved to the University of Sheffield, where she worked as a Research Associate in the Department of Molecular Biology and Biotechnology (MBB), working on multidisciplinary projects studying the cell wall and antimicrobial resistance in opportunistic pathogens.

Nicola currently works with academics in Oncology & Metabolism and the School of Health and Related Research (ScHARR)


Jonathan Field

Jonathan Field profile

Knowledge Exchange and Commercialisation Analyst

Jonathan completed his PhD at the University of Sheffield in the field of Biomaterials and Tissue Engineering, working between the School of Clinical Dentistry and the Department of Materials Science and Engineering. Following this, he worked in a research associate post in a collaborative project with the industry. The research included both materials for peripheral nerve and cardiovascular applications. Jonathan currently works with academics in the School of Clinical Dentistry and Infection, Immunity and Cardiovascular Disease


Richard Mead

Faculty Lead for Knowledge Exchange and Innovation

Richard is a Senior Lecturer in Translational Neuroscience at the University of Sheffield and the Faculty Lead for Knowledge Exchange and Innovation in the Faculty of Medicine, Dentistry and Health. He leads a research group focused on therapeutic development for Neurodegenerative diseases, particularly motor neurone disease/amyotrophic lateral sclerosis (MND/ALS) and Parkinson's disease, working closely with pharma and biotech companies. He is also co-founder and CSO of Keapstone Therapeutics, a spin-out from the University of Sheffield investigating KEAP1 inhibitors for disease modification in ALS and PD.


Professor Simon Dixon

Academic Lead for Innovation

Simon is responsible for linking non-clinical aspects of the Faculty with the work for the Sheffield Healthcare Gateway. This principally relates to the work of the School of Health and Related Research (ScHARR) where he was Director of Health Economics and Decision Science for over 6 years. ScHARR has a large portfolio of Innovation and Knowledge Transfer (IKT) activities covering consultancy for global pharmaceutical companies, the NHS and third sector organisations.  In addition, ScHARR hosts several regional units that are central to IKT activities including the National Institute for Health Research funded Yorkshire and Humber Research Design Service (YH RDS), the Collaboration for Leadership in Applied Health Research and care, Yorkshire and Humber (CLAHRC YH) and the Sheffield Clinical Trials Research Unit (CTRU).  Simon’s personal IKT work includes undertaking economic analysis as part of grants from NIHR i4i, MRC DPFS, European Commission 7th Framework Programme, plus training and consulting for several multinational pharmaceutical companies.


Dr Michael Murray

Michael Murray Healthcare Gateway Profile

Royal Society Entrepreneur in Residence

In April 2019, Dr Michael Murray commenced as a Royal Society Entrepreneur in Residence at the University of Sheffield and hosted by the Faculty of Medicine, Dentistry and Health. He works closely with the Sheffield Healthcare Gateway and with the Research Services Impact and IP team. The Royal Society funds Michael’s post which is part-time (one day a week) for 3 years. As part of Michael’s role, he is delivering training which outlines how, for example, a biochemical or biological reaction in an Eppendorf tube might be turned into a globally available medicine. Recordings of Michael’s Training sessions are available to be viewed by staff and students at the University of Sheffield via this link.

Principal at Murray International Partners, Michael is a deal-maker and commercial intellectual property (IP) specialist who has been working in technology transfer in the biopharmaceutical industry since 1996. His clients range from universities and research institutes, through start-ups and SMEs, to mid-tier and major multinational companies. In the UK, as well as his role at the University of Sheffield, he is a mentor for the University of Cambridge’s technology transfer business, Cambridge Enterprise, and he sits on the Research Strategy Board for the medical charity, Coeliac UK. Further afield, he is a member of the International Advisory Board of China’s International Technology Transfer Network (which operates under the auspices of the Ministry of Science and Technology) and he serves on the Senior Advisory Board of the International Chamber of Innovation, Commerce & Enterprise (Japan).



A world top-100 university

We're a world top-100 university renowned for the excellence, impact and distinctiveness of our research-led learning and teaching.